Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

This study tests a new ointment called HW211026 for actinic keratosis, rough skin spots caused by sun damage that can turn into skin cancer. About 80 adults with at least two spots on their face will use the ointment to see if it clears the spots completely and safely. The goal i…

This early-phase study tests whether a new tablet called HW241045 is safe for people. It involves 102 healthy volunteers aged 18 to 45. The goal is to find the right dose and check for side effects, as a first step toward treating idiopathic pulmonary fibrosis, a serious lung-sca…

This study tests an experimental drug called HW091077 in 180 adults with a persistent cough lasting at least a year that hasn't improved with standard treatment. Participants will receive either the drug or a placebo for 4 weeks to see if it reduces coughing and improves quality …

This early-stage study tests the safety of a new tablet called HW252001 in 98 healthy adults aged 18 to 55. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. The goal is to gather safety information, n…